Cardiovascular Risk Predictors in Patients With Psoriasis

I.M. Sechenov First Moscow State Medical University

Status: Completed

Conditions: Psoriasis; Cardiovascular Diseases

Study type: Observational

Funder types: Other

Identifiers

NCT05200598

22-21

Details and patient eligibility

About

The investigators are planning to find the right modification of traditionally used risk scores (PASI, DLQI) in patients with psoriasis of different severity to guide the treatment that could potentially extend life, improve cardiovascular outcomes and quality of life in patients with psoriasis and cardiovascular risk factors in a prospective observational study. The traditionally excluded groups of older patients with diabetes mellitus, decreased kidney function and those with potentially worse prognosis are going to be included in the study. As it's known, the number of those patients is on the rise each year and require a close attention of multidisciplinary teams.

Enrollment: 200 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age over 18 years
• Written informed consent of the patient to participate in the study

Exclusion criteria

• Age under 18
• Pregnancy, lactation
• Very high cardiovascular risk
• Life-threatening, independently influencing prognosis and disabling diseases,
• Mental disorders that do not allow to give informed consent or answer questions adequately
• Refuse of the patient to participate in the study

Trial design

200 participants in 4 patient groups

Mild psoriasis

Moderate psoriasis

Severe psoriasis

Patients without psoriasis